|
6 Companies |
|
10 Products |
|
10 Products |
|
13 Mechanisms of Action |
|
0 Trials |
|
280 News |
|
| «123456» |
- Trial completion: A Trial Comparing Treatment With the Springfusor Infusion Pump to the IV Magnesium Sulfate Regimen (clinicaltrials.gov) - Oct 4, 2016
P4, N=200, Completed, Sponsor: Gynuity Health Projects
Recruiting --> Completed
- Enrollment change, Trial withdrawal, Trial primary completion date: Maternal and Neonatal Outcomes of the Use of Vasopressors to Treat Hypotension During Spinal Anesthesia for Cesarean (clinicaltrials.gov) - Sep 7, 2016
P3, N=0, Withdrawn, Sponsor: Instituto Materno Infantil Prof. Fernando Figueira
Recruiting --> Completed N=55 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Jun 2012 --> Jun 2014
- aspirin / Generic mfg.
Trial primary completion date: PROVAS: Prevention of Preeclampsia With Aspirin in Recipients of Donated Oocytes. (clinicaltrials.gov) - Aug 23, 2016
P3, N=372, Recruiting, Sponsor: Instituto de Investigacion Sanitaria La Fe
N=55 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Jun 2012 --> Jun 2014 Trial primary completion date: Oct 2015 --> Dec 2017
- Biomarker, Trial primary completion date, Adverse events: Placental Growth and Adverse Pregnancy Outcomes (clinicaltrials.gov) - Aug 19, 2016
P=N/A, N=1200, Active, not recruiting, Sponsor: University of Pennsylvania
Trial primary completion date: Oct 2015 --> Dec 2017 Trial primary completion date: Jun 2013 --> Oct 2016
- Enrollment change: Left Ventricular and Endothelial Function in Preeclampsia (clinicaltrials.gov) - Aug 4, 2016
P1/2, N=39, Completed, Sponsor: Norwegian University of Science and Technology
Trial primary completion date: Jun 2013 --> Oct 2016 N=50 --> 39
- Trial primary completion date: MAG-PP: Magnesium Sulfate in Pregnancy and Postpartum (clinicaltrials.gov) - Jun 30, 2016
P2/3, N=280, Recruiting, Sponsor: Complejo Hospitalario Dr. Arnulfo Arias Madrid
N=50 --> 39 Trial primary completion date: Mar 2016 --> Oct 2016
- Enrollment closed: ESTEEM - Effect of Simple, Targeted Diet in Pregnant Women With Metabolic Risk Factors on Pregnancy Outcomes (clinicaltrials.gov) - Jun 30, 2016
P=N/A, N=3439, Active, not recruiting, Sponsor: Queen Mary University of London
Trial primary completion date: Mar 2016 --> Oct 2016 Recruiting --> Active, not recruiting
- Trial completion: ANGIODYS: Consequences of Antiangiogenic Factors Involved in Preeclampsia on Intra-uterine Growth Restricted Preterm Newborn (clinicaltrials.gov) - Jun 24, 2016
P=N/A, N=33, Completed, Sponsor: Assistance Publique - H
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- aspirin / Generic mfg.
Enrollment closed, Enrollment change: PERASTUN: Prevention of Pre-eclampsia and SGA by Low-Dose Aspirin in Nulliparous Women With Abnormal First-trimester Uterine Artery Dopplers (clinicaltrials.gov) - Jun 20, 2016
P4, N=1106, Active, not recruiting, Sponsor: University Hospital, Tours
Active, not recruiting --> Completed Recruiting --> Active, not recruiting | N=4972 --> 1106
- | enoxaparin sodium / Generic mfg.
Enrollment closed, Trial primary completion date: HOPPE: Low Weight Heparin prOphylaxis for Placental-Mediated Complications of PrEgnancy (clinicaltrials.gov) - Jun 10, 2016
P3, N=361, Active, not recruiting, Sponsor: Hospital Universitari Vall d'Hebron Research Institute
Recruiting --> Active, not recruiting | N=4972 --> 1106 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Jun 2016
- ||| Trial completion, Enrollment change, Trial primary completion date, Adverse events: Predicting Complications in Women With Toxaemia (clinicaltrials.gov) - Jun 1, 2016
P=N/A, N=650, Completed, Sponsor: University of British Columbia
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Jun 2016 Active, not recruiting --> Completed | N=2000 --> 650 | Trial primary completion date: Sep 2015 --> Dec 2010
- Enrollment closed, Trial primary completion date: SNAP-HT: Self-management of Postnatal Anti-hypertensive Treatment: a Trial Development Pilot Study (clinicaltrials.gov) - May 31, 2016
P=N/A, N=101, Active, not recruiting, Sponsor: University of Oxford
Active, not recruiting --> Completed | N=2000 --> 650 | Trial primary completion date: Sep 2015 --> Dec 2010 Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2016 --> Nov 2016
- Trial completion, HEOR: Evaluation of a Physical Therapy Protocol on Quality of Life Musculoskeletal Pain and Anxiety in Women With Preeclampsia (clinicaltrials.gov) - May 12, 2016
P=N/A, N=60, Completed, Sponsor: University of Sao Paulo
Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2016 --> Nov 2016 Active, not recruiting --> Completed
- aspirin / Generic mfg.
Biomarker, Enrollment closed, Enrollment change, Trial initiation date, Trial primary completion date: ASPRE: Combined Multi-marker Screening and Treatment With Aspirin for Pre-eclampsia Prevention (clinicaltrials.gov) - May 2, 2016
P3, N=2, Active, not recruiting, Sponsor: Rabin Medical Center
Active, not recruiting --> Completed Not yet recruiting --> Active, not recruiting | N=3000 --> 2 | Initiation date: Nov 2014 --> Dec 2015 | Trial primary completion date: Feb 2016 --> Nov 2016
- aspirin / Generic mfg.
Enrollment closed, Trial primary completion date: Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial. (clinicaltrials.gov) - Apr 19, 2016
P2, N=50, Active, not recruiting, Sponsor: Centre Hospitalier Universitaire de Qu
Not yet recruiting --> Active, not recruiting | N=3000 --> 2 | Initiation date: Nov 2014 --> Dec 2015 | Trial primary completion date: Feb 2016 --> Nov 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2016 --> Oct 2016
- Enrollment closed, Enrollment change, Trial primary completion date: Accuracy Assessment of an Automatic Blood Pressure Measurement Device in Pregnant Women (clinicaltrials.gov) - Apr 13, 2016
P=N/A, N=43, Active, not recruiting, Sponsor: William Marsh Rice University
Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2016 --> Oct 2016 Not yet recruiting --> Active, not recruiting | N=70 --> 43 | Trial primary completion date: Apr 2016 --> Dec 2016
- Enrollment closed, Enrollment change, Trial primary completion date: Assessment of a Syringe Pump to Pre-eclamptic Women in a Low-resource Hospital (clinicaltrials.gov) - Apr 13, 2016
P=N/A, N=34, Active, not recruiting, Sponsor: William Marsh Rice University
Not yet recruiting --> Active, not recruiting | N=70 --> 43 | Trial primary completion date: Apr 2016 --> Dec 2016 Recruiting --> Active, not recruiting | N=50 --> 34 | Trial primary completion date: Apr 2016 --> Dec 2016
- ||||| ATryn (antithrombin) / LFB SA, Knight Therap
Enrollment closed: PRESERVE-1: Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (clinicaltrials.gov) - Apr 11, 2016
P3, N=120, Active, not recruiting, Sponsor: rEVO Biologics
Recruiting --> Active, not recruiting | N=50 --> 34 | Trial primary completion date: Apr 2016 --> Dec 2016 Recruiting --> Active, not recruiting
- Atenativ (human antithrombin III) / Octapharma
Enrollment open, Trial initiation date, Trial primary completion date: Atenativ Effect on Uterine Blood Flow and Preeclampsia (clinicaltrials.gov) - Mar 23, 2016
P4, N=6, Recruiting, Sponsor: Vastra Gotaland Region
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting | Initiation date: Jan 2015 --> Jan 2016 | Trial primary completion date: Dec 2015 --> Dec 2017
- enoxaparin sodium / Generic mfg.
Trial completion: Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome (clinicaltrials.gov) - Feb 23, 2016
P=N/A, N=144, Completed, Sponsor: HaEmek Medical Center, Israel
Not yet recruiting --> Recruiting | Initiation date: Jan 2015 --> Jan 2016 | Trial primary completion date: Dec 2015 --> Dec 2017 Active, not recruiting --> Completed
- remifentanil / Generic mfg., dexmedetomidine / Generic mfg.
Intubation: Dexmedetomidine vs. Remifentanil for Pre-eclampsia During Caesarean Delivery (clinicaltrials.gov) - Feb 9, 2016
P2, N=36, Recruiting, Sponsor: Mansoura University
Active, not recruiting --> Completed Trial primary completion date: Oct 2015 --> Feb 2016
- Enrollment closed, Trial primary completion date, Head-to-Head, Adherence: MICA: Cornell University-Micronutrient Initiative Calcium Supplementation Study (clinicaltrials.gov) - Jan 28, 2016
P=N/A, N=1032, Active, not recruiting, Sponsor: Cornell University
Trial primary completion date: Oct 2015 --> Feb 2016 Completed --> Active, not recruiting | Trial primary completion date: Jun 2015 --> Jun 2016
- aspirin / Generic mfg.
Trial primary completion date: Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial. (clinicaltrials.gov) - Jan 27, 2016
P2, N=50, Recruiting, Sponsor: Centre Hospitalier Universitaire de Qu
Completed --> Active, not recruiting | Trial primary completion date: Jun 2015 --> Jun 2016 Trial primary completion date: Dec 2015 --> Mar 2016
- Trial completion, Head-to-Head, Adherence: MICA: Cornell University-Micronutrient Initiative Calcium Supplementation Study (clinicaltrials.gov) - Jan 25, 2016
P=N/A, N=1032, Completed, Sponsor: Cornell University
Trial primary completion date: Dec 2015 --> Mar 2016 Active, not recruiting --> Completed
- | enoxaparin sodium / Generic mfg.
Trial completion, Trial primary completion date: HEPEPE: Prevention of Maternal and Perinatal Complications by Enoxaparin in Women With Previous Severe Preeclampsia (clinicaltrials.gov) - Jan 20, 2016
P3, N=257, Completed, Sponsor: Assistance Publique - H
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Feb 2015 --> Nov 2015
- irbesartan / Generic mfg.
Trial primary completion date: Preeclampsia: A Marker for Future Cardiovascular Risk in Women (clinicaltrials.gov) - Jan 17, 2016
P=N/A, N=150, Recruiting, Sponsor: Brigham and Women's Hospital
Active, not recruiting --> Completed | Trial primary completion date: Feb 2015 --> Nov 2015 Trial primary completion date: Sep 2015 --> Sep 2016
- Trial completion: Phase I Study of Nicotinamide for Early Onset Preeclampsia (clinicaltrials.gov) - Jan 5, 2016
P1, N=10, Completed, Sponsor: University of North Carolina, Chapel Hill
Trial primary completion date: Sep 2015 --> Sep 2016 Recruiting --> Completed
- | Trial completion, Trial primary completion date: MAG-PIP: Magnesium Sulfate During the Postpartum in Women With Severe Preeclampsia (clinicaltrials.gov) - Dec 29, 2015
P2/3, N=1114, Completed, Sponsor: Complejo Hospitalario Dr. Arnulfo Arias Madrid
Recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Jun 2016 --> Dec 2015
- Enrollment change, Trial termination, Trial primary completion date: ADENA: Usefulness of Extracorporeal Removal of sFLT-1 in Women With Very Early Severe Preeclampsia (clinicaltrials.gov) - Dec 22, 2015
P2, N=2, Terminated, Sponsor: Assistance Publique - H
Recruiting --> Completed | Trial primary completion date: Jun 2016 --> Dec 2015 N=17 --> 2 | Recruiting --> Terminated | Trial primary completion date: Nov 2017 --> Nov 2015; Safety of patients : CSI recommandation and promotor decision
- Trial completion: Improving Maternal and Child Health in India: Evaluating Demand and Supply Side Strategies (IMATCHINE) (clinicaltrials.gov) - Dec 16, 2015
P=N/A, N=14990, Completed, Sponsor: Duke University
N=17 --> 2 | Recruiting --> Terminated | Trial primary completion date: Nov 2017 --> Nov 2015; Safety of patients : CSI recommandation and promotor decision Active, not recruiting --> Completed
- | Trial completion: Induction With Foley OR Misoprostol (INFORM) Study (clinicaltrials.gov) - Dec 14, 2015
P3, N=602, Completed, Sponsor: University of Liverpool
Active, not recruiting --> Completed Recruiting --> Completed
- |||| nifedipine immediate release / Generic mfg., labetalol / Generic mfg.
Enrollment open, Enrollment change, Trial initiation date, Trial primary completion date: Oral Antihypertensive Regimens for Management of Hypertension in Pregnancy (clinicaltrials.gov) - Dec 12, 2015
P4, N=894, Recruiting, Sponsor: Gynuity Health Projects
Recruiting --> Completed Not yet recruiting --> Recruiting | N=671 --> 894 | Initiation date: Nov 2014 --> Apr 2015 | Trial primary completion date: Dec 2015 --> Jun 2017
- Trial primary completion date: A Trial Comparing Treatment With the Springfusor Infusion Pump to the IV Magnesium Sulfate Regimen (clinicaltrials.gov) - Dec 11, 2015
P4, N=200, Recruiting, Sponsor: Gynuity Health Projects
Not yet recruiting --> Recruiting | N=671 --> 894 | Initiation date: Nov 2014 --> Apr 2015 | Trial primary completion date: Dec 2015 --> Jun 2017 Trial primary completion date: Oct 2015 --> Jan 2016
- Enrollment open: CPAP in Preeclampsia (clinicaltrials.gov) - Dec 11, 2015
P=N/A, N=30, Recruiting, Sponsor: University of Sydney
Trial primary completion date: Oct 2015 --> Jan 2016 Not yet recruiting --> Recruiting
- Trial primary completion date: ESTEEM - Effect of Simple, Targeted Diet in Pregnant Women With Metabolic Risk Factors on Pregnancy Outcomes (clinicaltrials.gov) - Dec 4, 2015
P=N/A, N=3640, Recruiting, Sponsor: Queen Mary University of London
Not yet recruiting --> Recruiting Trial primary completion date: Feb 2016 --> Aug 2016
- | carbetocin / Generic mfg.
Enrollment change: Prevention of Postpartum Hemorrhage in Patients With Severe Preeclampsia Using Carbetocin Versus Misoprostol (clinicaltrials.gov) - Nov 27, 2015
P3, N=60, Completed, Sponsor: khalid abd aziz mohamed
Trial primary completion date: Feb 2016 --> Aug 2016 N=120 --> 60
- Trial termination: Gene Expression In Pregnancies Complicated by Preeclampsia (clinicaltrials.gov) - Oct 22, 2015
P=N/A, N=125, Terminated, Sponsor: University of Rochester
PI email now homonq@ufl.edu. Phone is 352-273-7675
- | carbetocin / Generic mfg.
Trial initiation date, Trial primary completion date: Prevention of Postpartum Hemorrhage in Patients With Severe Preeclampsia Using Carbetocin Versus Misoprostol (clinicaltrials.gov) - Oct 22, 2015
P3, N=120, Completed, Sponsor: khalid abd aziz mohamed
Phone is 352-273-7675 Initiation date: Mar 2014 --> Mar 2013 | Trial primary completion date: Jul 2014 --> Aug 2015
- Trial completion, Trial primary completion date: HUPP: Hypertension and Urine Protease Activity in Preeclampsia (clinicaltrials.gov) - Oct 16, 2015
P=N/A, N=35, Completed, Sponsor: Odense University Hospital
Initiation date: Mar 2014 --> Mar 2013 | Trial primary completion date: Jul 2014 --> Aug 2015 Recruiting --> Completed | Trial primary completion date: Jun 2015 --> Oct 2015
- Trial completion, Enrollment change, Trial primary completion date: Urine-plasminogen as a Predictor for Development Of Preeclampsia in Pregnant Women With Type 1 Diabetes Mellitus (clinicaltrials.gov) - Oct 16, 2015
P=N/A, N=85, Completed, Sponsor: Odense University Hospital
Recruiting --> Completed | Trial primary completion date: Jun 2015 --> Oct 2015 Recruiting --> Completed | N=130 --> 85 | Trial primary completion date: Apr 2015 --> Sep 2015
- Enrollment closed: Health Improvement After Pregnancy (HIP) Program Randomized Control Trial (clinicaltrials.gov) - Oct 15, 2015
P=N/A, N=96, Active, not recruiting, Sponsor: Queen's University
Recruiting --> Completed | N=130 --> 85 | Trial primary completion date: Apr 2015 --> Sep 2015 Recruiting --> Active, not recruiting
- | Trial completion, Enrollment change: RAAPID-II: Removal of Anti-Angiogenic Proteins in Preeclampsia Before Delivery (clinicaltrials.gov) - Sep 29, 2015
P1/2, N=11, Completed, Sponsor: Massachusetts General Hospital
Recruiting --> Active, not recruiting Active, not recruiting --> Completed | N=16 --> 11
- |||| ATryn (antithrombin) / LFB SA, Knight Therap
Trial primary completion date: PRESERVE-1: Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (clinicaltrials.gov) - Sep 24, 2015
P3, N=120, Recruiting, Sponsor: rEVO Biologics
Active, not recruiting --> Completed | N=16 --> 11 Trial primary completion date: Aug 2015 --> Jun 2016
- remifentanil / Generic mfg., dexmedetomidine / Generic mfg.
Intubation: Dexmedetomidine vs. Remifentanil for Pre-eclampsia During Caesarean Delivery (clinicaltrials.gov) - Sep 24, 2015
P2, N=36, Recruiting, Sponsor: Mansoura University
Trial primary completion date: Aug 2015 --> Jun 2016 Trial primary completion date: Jul 2015 --> Oct 2015
- | Enrollment closed: RAAPID-II: Removal of Anti-Angiogenic Proteins in Preeclampsia Before Delivery (clinicaltrials.gov) - Sep 24, 2015
P1/2, N=16, Active, not recruiting, Sponsor: Massachusetts General Hospital
Trial primary completion date: Jul 2015 --> Oct 2015 Recruiting --> Active, not recruiting
- Enrollment open: ESTEEM - Effect of Simple, Targeted Diet in Pregnant Women With Metabolic Risk Factors on Pregnancy Outcomes (clinicaltrials.gov) - Aug 24, 2015
P=N/A, N=3640, Recruiting, Sponsor: Queen Mary University of London
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- aspirin / Generic mfg.
Trial primary completion date: Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial. (clinicaltrials.gov) - Aug 21, 2015
P2, N=50, Recruiting, Sponsor: Centre Hospitalier Universitaire de Qu
Not yet recruiting --> Recruiting Trial primary completion date: May 2015 --> Dec 2015
- Trial completion, Enrollment change: Study of Positive Airway Pressure in Preeclampsia to Reduce Blood Pressure (clinicaltrials.gov) - Aug 19, 2015
P=N/A, N=125, Completed, Sponsor: University of Michigan
Trial primary completion date: May 2015 --> Dec 2015 Active, not recruiting --> Completed | N=160 --> 125
- Enrollment change, Trial termination, Trial primary completion date: Detecting Early Onset Pre-eclampsia and Use of Placental Growth Factor (PlGF) for Marker of Trisomy 21 (clinicaltrials.gov) - Aug 12, 2015
P=N/A, N=370, Terminated, Sponsor: OVO R & D
Active, not recruiting --> Completed | N=160 --> 125 N=2000 --> 370 | Recruiting --> Terminated | Trial primary completion date: Apr 2017 --> Jun 2015; The technique has been approved and validated
- | aspirin / Generic mfg.
Enrollment open: PROVAS: Prevention of Preeclampsia With Aspirin in Recipients of Donated Oocytes. (clinicaltrials.gov) - Jul 22, 2015
P3, N=372, Recruiting, Sponsor: Instituto de Investigacion Sanitaria La Fe
N=2000 --> 370 | Recruiting --> Terminated | Trial primary completion date: Apr 2017 --> Jun 2015; The technique has been approved and validated Not yet recruiting --> Recruiting